Background: Sodium glucose cotransporter 2 receptor inhibitor (SGLT2i) dapagliflozin protects the renal function of individuals with coronary artery disease (CAD) and reduces incidence of contrast-induced acute kidney injury (CI-AKI) among individuals having percutaneous coronary...
Open access
Research Article10.9734/ca/2024/v13i4454
Background: Coronary bifurcation lesions (CBLs) encompass stenotic segments of the coronary artery that are situated near or encroach upon the origin of a major side branch. These lesions are implicated in nearly 20% of all percutaneous coronary intervention. The Objective of thi...
Open access
Research Article10.9734/ca/2024/v13i4436
Background: Contrast-induced acute kidney injury (CIAKI) it is an important complication of diagnostic and interventional procedures in cardiology. This work aimed to to investigate the preventive role of colchicine on CI-AKI in patients undergoing elective PCI considering to its...
Open access
Research Article10.9734/ca/2024/v13i3430